HUMA
Humacyte, Inc.
NASDAQ · USHealthcareBiotechnology
$0.66-1.28%
Price as of Jul 20, 2026
HUMA valuation
Humacyte, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.88x
- P/S forward
- 1.75x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.53x
- Price / sales
- 72.27x
- Price / cash flow
- -1.43x
Enterprise value
- Enterprise value
- $163.1M
- EV / sales
- 80.88x
- EV / EBITDA
- -2.04x
- EV / EBIT
- -1.43x
- Market cap
- $145.7M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.